Kanada - Prancis - Health Canada

lancome canada - octocrilène; octisalate; avobenzone - crème - 7.0%; 5.0%; 3.0% - octocrilène 7.0%; octisalate 5.0%; avobenzone 3.0% - sunscreen agents

Kanada - Prancis - Health Canada

lancome canada - homosalate; oxybenzone; octisalate; avobenzone; octocrilène - lotion - 15.0%; 6.0%; 5.0%; 3.0%; 5.0% - homosalate 15.0%; oxybenzone 6.0%; octisalate 5.0%; avobenzone 3.0%; octocrilène 5.0% - sunscreen agents

Kanada - Prancis - Health Canada

lancome canada - ensulizole; octinoxate - crème - 1.5%; 7% - ensulizole 1.5%; octinoxate 7% - sunscreen agents

Kanada - Prancis - Health Canada

lancome canada - octinoxate; ensulizole - crème - 7.0%; 1.5% - octinoxate 7.0%; ensulizole 1.5% - sunscreen agents

Kanada - Prancis - Health Canada

lancome canada - octinoxate; dioxyde de titane - lotion - 7.5%; 5.8% - octinoxate 7.5%; dioxyde de titane 5.8% - sunscreen agents

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ciclosporinum - capsules - ciclosporinum 25 mg, ethanolum anhydricum 25 mg, propylenglycolum 25 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 101.25 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum), propylenglycolum 21.42 mg, gelatina, e 172 (nigrum), drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ciclosporinum - capsules - ciclosporinum 50 mg, ethanolum anhydricum 50 mg, propylenglycolum 50 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 202.5 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum), propylenglycolum 40.36 mg, gelatina, drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ciclosporinum - capsules - ciclosporinum 100 mg, ethanolum anhydricum 100 mg, propylenglycolum 100 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 405 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum), propylenglycolum 48.31 mg, gelatina, e 172, drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ciclosporinum - capsules - ciclosporinum 10 mg, ethanolum anhydricum 10 mg, propylenglycolum 10 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 40.5 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum) 6.9 mg, propylenglycolum 10.8 mg, gelatina, drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

Kanada - Prancis - Health Canada

glaxosmithkline inc - vaccin polysaccharidique capsulaire vi contre salmonella typhi - liquide - 25mcg - vaccin polysaccharidique capsulaire vi contre salmonella typhi 25mcg - vaccines